Bright Uro, Inc., the company transforming care for lower urinary tract dysfunction (LUTD) through innovations in urodynamics, today announced the addition of two accomplished medical device pioneers to its Board: Joseph DeVivo, President, CEO and Chairman of the Board of Butterfly Network, will serve as a Board Director, and Ted Lamson, Ph.D., co-founder and co-inventor of the UroLift® System at NeoTract, will serve as a Strategic Advisor to the Board of Directors. The appointments come as Bright Uro accelerates commercialization of the Glean® Urodynamics System — the first wireless, catheter-free urodynamics platform to offer multi-channel studies — and continues development of Urodynamic Intelligence™, its proprietary AI and machine learning platform for interpreting urodynamic data. Read More